SUNDAY, 29th

Jahan Marcu, Ph.D., is currently the Senior Scientist and Chief Auditor for Americans for Safe Access and the Patient Focused Certification (PFC) Program. His is also on the Board of Directors of the International Association for Cannabinoids as Medicine (IACM).  Dr. Marcu is the Director of Research and Development at Green Standard Diagnostics Inc. He received his Ph.D. for significant contributions to the study of the structure and function of the CB1 receptor, and the role of the endocannabinoid system in bone.  Before earning his Ph.D., Dr. Marcu worked at the California Pacific Medical Center Research Institute studying the anti-cancer properties of compounds from the cannabis plant (Published in the Journal of Molecular Cancer Therapeutics) and on analytical Cannabis research projects in Holland. He is also an author of the American Herbal Pharmacopeia's Cannabis Monograph and one of the auditors for the Patient Focused Certification (PFC) program; an enforcement and oversight program that ensures that basic product safety protocols are followed at Cannabis operations. Dr. Marcu is a recipient of the Billy Martin research award from the International Cannabinoid Research Society.

He effectively translates complex scientific concepts to a lay audience and is developing international networks of key cannabis researchers.  He has served as a volunteer for Americans for Safe Access (ASA) since 2003.  He has been invited to speak on the subject of cannabinoid science at universities, medical cannabis cooperatives, libraries, and high schools.  Dr. Marcu is a contributing author and/or editor of several publications including: O'Shaughnessy's: The Journal Of Cannabis In Clinical Practice (beyondthc.com), projectCBD.org, the West Coast Leaf (aka the Leaf), the Philadelphia examiner (www.examiner.com) , CannabisNow, the sensible science blog at freedomisgreen.com,  and Freedom Leaf Magazine  Dr. Marcu is also court qualified cannabis and synthetic cannabinoid expert. 

Dr. Suza A. Sisley practices medicine in Scottsdale, AZ and specializes in Internal Medicine and Psychiatry.  She is widely known for her research into potential medical uses of marijuana to treat veterans diagnosed with PTSD. Dr. Sisley's research is supported by the Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based nonprofit organization.

Dr. Sisley serves as Principal Investigator for the only FDA-approved randomized controlled trial looking at use of whole-plant marijuana (grown by NIDA) in combat veterans with treatment-resistant post-traumatic stress disorder PTSD.

Dr. Sisley graduated from Northern Arizona University with a degree in Chemistry/Pre-Med and a minor in Theater. She proceeded to Tucson where she completed her medical degree at the University of Arizona, College of Medicine. In 2000, Dr. Sisley completed her five-year Residency Training at Good Samaritan Regional Medical Center in the fields of Internal Medicine and Psychiatry. During her residency training, Dr. Sisley won the University of Arizona's House Staff Educator of the Year Award annually for 3 consecutive years.

Dr. Dustin Sulak is an integrative medicine pioneer with a focus in osteopathy, mind-body medicine, and medical cannabis. Dr. Sulak received undergraduate degrees in nutrition science and biology from Indiana University, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine, and completed an internship at Maine-Dartmouth Family Medicine Residency. Mentored by Andrew Weil, M.D. during his training, Dr. Sulak's clinical practice focuses on treating refractory conditions in adults and children with a variety of safe, alternative therapies in an individualized, health-centered approach.

Dr. Sulak is the founder of Integr8 Health in Falmouth and Maine Integrative Healthcare in Manchester, two integrative health practices in Maine that treat over 18,000 patients with medical cannabis. He has helped set the standard of care for the use of medical cannabis

 in a wide variety of conditions, including pain, spasticity, seizure disorders, PTSD, and more. Dr. Sulak lectures nationally to medical providers and patients on the appropriate use of medical cannabis, and continues to explore the therapeutic potential of this ancient yet emerging trend in medicine.